Why RSV Vaccines Matter
Sponsored by: RSVTrialNow.com
RSV (respiratory syncytial virus) and Your Risk You may never have heard of RSV before. But if you are age 60 or older and have a lung or heart condition or a weak immune system, you should know that you are at risk for this common virus.
What is RSV? RSV is a common seasonal virus, similar to the flu, that infects the lungs and the airways in about 64 million adults and young children worldwide – every year. It can cause cold-like symptoms, difficulty breathing and/or pneumonia. It is very contagious and is spread by coughing, sneezing, nasal and oral secretions, so is easily passed around in shared living spaces such as long-term care facilities.
Who is at Risk?
- Older adults, especially those 65 years and older
- Adults with chronic heart or lung disease
- Adults with weakened immune systems
What can you do?
- your hands frequently and use hand sanitizer
- Avoid touching your face – eyes, nose and mouth
- Don’t have close contact or kiss, share utensils or cups with anyone with cold-like symptoms
- Cover your coughs and sneezes
- Clean and disinfect surfaces and objects
Stay home if you are feeling unwell Join an RSV vaccine trial!
There is no current vaccine for RSV.
There is no vaccine to offer protection right now, but researchers are working hard to develop one.
Participating in an RSV vaccine trial provides you access to specialists who are knowledgeable about RSV and you may receive a study vaccine that is potentially effective against RSV. More importantly, you will be making a contribution to research that may result in a future vaccine that can protect you and others from RSVTags: RSV Virus